Weekly doses of prenatal steroids do not improve overall outcome and are associated with lower birthweight and smaller size for gestational age compared to a single dose, according to a study published in the September issue of the American Journal of Obstetrics & Gynecology.
Weekly doses of prenatal steroids do not improve overall outcome and are associated with lower birthweight and smaller size for gestational age compared to a single dose, according to a study published in the September issue of the American Journal of Obstetrics & Gynecology.
Ronald J. Wapner, MD, of Columbia University College of Physicians and Surgeons in New York, and colleagues conducted a study of women between 23 and 32 weeks' gestation who had received one course of steroids 7 to 10 days earlier, with a view to randomizing 2,400 women to receive weekly betamethasone or placebo.
The independent data and safety monitoring committee terminated the study when 495 women were enrolled, because although the repeated doses of steroids significantly reduced administration of neonatal surfactants, mechanical ventilation, and pneumothoraces, they did not significantly reduce composite primary morbidity. They were also associated with lower birthweight and an increased number of infants who were small for gestational age.
Wapner RJ, Sorokin Y, Thom EA, et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. Am J Obstet Gynecol. 2006;195,633-642.
Link between prenatal air pollution and reduced lung function in offspring reported
July 25th 2024Higher prenatal exposure to PM2.5 pollution is associated with reduced lung volume and airflow limitation in children, highlighting the critical impact of air pollution on in utero lung development.
Read More
Cut costs observed from out-of-home care in children with prenatal substance exposure
July 24th 2024A recent study reveals that while children exposed to maternal substance use face higher hospital costs up to age 20 years, out-of-home care significantly mitigates this financial burden.
Read More
Global progress in neonatal tetanus elimination from 2000 to 2022
July 18th 2024Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
Read More
PreTRM test shows efficacy in reducing severe neonatal morbidity and mortality
July 18th 2024The PreTRM test, a blood-based biomarker test for predicting preterm birth risk, has demonstrated significant efficacy in lowering severe neonatal morbidity and mortality, as reported by Sera Prognostics Inc.
Read More